FFCP PHASE1:Mm9::chr7:121897273..121897278,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=233752|HGNC=|MCL_coexpression_id=112|UniProt=|association_with_transcript=38bp_to_ENSMUST00000139670_5end|description=CAGE_peak_21_at_Insc_5end|id=chr7:121897273..121897278,+|ontology_enrichment_celltype=CL:0000325!8.47e-23!2;CL:0000217!8.47e-23!2;CL:0000328!8.47e-23!2;CL:0002573!8.47e-23!2;CL:0002376!8.47e-23!2;CL:0000218!8.47e-23!2;CL:0000692!8.47e-23!2;CL:0002377!8.47e-23!2;CL:0002375!8.47e-23!2;CL:0000215!1.46e-15!3;CL:0000630!1.46e-15!3;CL:0000333!1.50e-10!10;CL:0000095!1.50e-10!10;CL:0000243!1.50e-10!10;CL:0000123!1.50e-10!10;CL:0000125!1.50e-10!10;CL:0000030!1.50e-10!10;CL:0000339!1.50e-10!10;CL:0000864!8.63e-07!2;CL:0000878!8.63e-07!2;CL:0000129!8.63e-07!2|ontology_enrichment_celltype_v019_2=CL:0000217,5.75e-23,2;CL:0000328,5.75e-23,2;CL:0002573,5.75e-23,2;CL:0002376,5.75e-23,2;CL:0000218,5.75e-23,2;CL:0000692,5.75e-23,2;CL:0002377,5.75e-23,2;CL:0002375,5.75e-23,2;CL:0000215,8.02e-16,3|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000010!2.00e-16!11;UBERON:0000011!1.04e-15!3|ontology_enrichment_uberon_v019_2=UBERON:0000010,5.67e-17,11;UBERON:0000011,1.12e-15,3|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.299600110518405,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.075726193333184,1.66257432234928,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.180062129805349,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.210289948564127,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238968797952552,1.33679204449436,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.307435147943927,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p21@Insc}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:233752 | |||
|HGNC= | |||
|MCL_coexpression_id=112 | |||
|TSSclassifier=NA | |||
|UniProt= | |||
|association_with_transcript=38bp_to_ENSMUST00000139670_5end | |||
|cluster_id=chr7:121897273..121897278,+ | |||
|description=CAGE_peak_21_at_Insc_5end | |||
|id=chr7:121897273..121897278,+ | |||
|ontology_enrichment_celltype=CL:0000325!8.47e-23!2;CL:0000217!8.47e-23!2;CL:0000328!8.47e-23!2;CL:0002573!8.47e-23!2;CL:0002376!8.47e-23!2;CL:0000218!8.47e-23!2;CL:0000692!8.47e-23!2;CL:0002377!8.47e-23!2;CL:0002375!8.47e-23!2;CL:0000215!1.46e-15!3;CL:0000630!1.46e-15!3;CL:0000333!1.50e-10!10;CL:0000095!1.50e-10!10;CL:0000243!1.50e-10!10;CL:0000123!1.50e-10!10;CL:0000125!1.50e-10!10;CL:0000030!1.50e-10!10;CL:0000339!1.50e-10!10;CL:0000864!8.63e-07!2;CL:0000878!8.63e-07!2;CL:0000129!8.63e-07!2 | |||
|ontology_enrichment_celltype_v019_2=CL:0000217,5.75e-23,2;CL:0000328,5.75e-23,2;CL:0002573,5.75e-23,2;CL:0002376,5.75e-23,2;CL:0000218,5.75e-23,2;CL:0000692,5.75e-23,2;CL:0002377,5.75e-23,2;CL:0002375,5.75e-23,2;CL:0000215,8.02e-16,3 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000010!2.00e-16!11;UBERON:0000011!1.04e-15!3 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000010,5.67e-17,11;UBERON:0000011,1.12e-15,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.299600110518405,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.075726193333184,1.66257432234928,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.180062129805349,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.210289948564127,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238968797952552,1.33679204449436,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.307435147943927,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p21@Insc | |||
}} |
Revision as of 02:18, 4 August 2015
Short description: | p21@Insc |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_21_at_Insc_5end |
Coexpression cluster: | MCL_coexpression_mm9:112 |
Association with transcript: | 38bp_to_ENSMUST00000139670_5end |
EntrezGene: | 233752 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
insulating cell | 5.75e-23 | 2 |
myelin accumulating cell | 5.75e-23 | 2 |
Schwann cell | 5.75e-23 | 2 |
non-myelinating Schwann cell | 5.75e-23 | 2 |
myelinating Schwann cell;;Schwann cell | 5.75e-23 | 2 |
terminal Schwann cell | 5.75e-23 | 2 |
immature Schwann cell | 5.75e-23 | 2 |
Schwann cell precursor | 5.75e-23 | 2 |
barrier cell | 8.02e-16 | 3 |
Ontology term | p-value | n |
---|---|---|
peripheral nervous system | 5.67e-17 | 11 |
parasympathetic nervous system | 1.12e-15 | 3 |